This acquisition provides one (1) whole genome sequencing instrument, including training and a one-year manufacturer's warranty, to support microbiological testing requirements
Active Purchase Order Awarded Last action
- Contract number
- 75F40126P00095
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $53,443
Award facts
- Opportunity
-
- Illumina MiSeq i100 System Solicitation · 75F40126Q22123 · Posted May 15, 2026
- Contract value 100% obligated
- $53,442.90 Current and potential, with all options
- Completion date 31% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Irvine, CA 92612, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a purchase order to Illumina, Inc. for one whole genome sequencing instrument on June 25, 2026, at a fixed price of $53,442.90.
The procurement was conducted on a sole-source basis under FAR Part 12 as a commercial product acquisition. The order specifies an Illumina MiSeq i100 sequencing system with training for up to three personnel and a one-year manufacturer's warranty covering parts, labor, and operational support. The system must support next-generation sequencing via sequencing-by-synthesis technology, deliver up to 25 gigabases of output, produce up to 50 million paired-end reads per run, achieve maximum read length of 2×300 base pairs with quality scores ≥Q30 at 85% of bases, employ RFID tracking, and fit a benchtop footprint not exceeding 16"×18"×26". Place of performance is the FDA Irvine Medical Products Laboratory, Irvine, California. Delivery is required within 60 days of award during regular business hours, Monday through Friday, 8:00 AM to 4:00 PM local time, excluding Federal holidays. The order is scheduled for completion by August 24, 2027.
Quick answers
Who was awarded contract 75F40126P00095?
75F40126P00095 was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on June 25, 2026.
How much is contract 75F40126P00095 worth?
The government has obligated $53,443 on 75F40126P00095.
Was contract 75F40126P00095 competed?
The extent of competition for 75F40126P00095 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award